Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$87.4M Sell
596,634
-153,253
-20% -$27.8M 0.37% 64
2026
Q1
$110M Sell
749,887
-232,899
-24% -$37.9M 0.7% 37
2025
Q4
$192M Buy
982,786
+881,583
+871% +$210M 1.21% 23
2025
Q3
$28.5M Buy
101,203
+37,040
+58% +$9.43M 0.2% 97
2025
Q2
$14M Sell
64,163
-78,318
-55% -$12.6M 0.12% 120
2025
Q1
$19.9M Buy
142,481
+83,418
+141% +$13.6M 0.38% 51
2024
Q4
$9.84M Buy
59,063
+56,929
+2,668% +$10.1M 0.17% 71
2024
Q3
$364K Buy
2,134
+515
+32% +$74.6K 0.01% 352
2024
Q2
$229K Sell
1,619
-1,464
-47% -$182K 0.01% 476
2024
Q1
$387K Sell
3,083
-1,158
-27% -$133K 0.01% 292
2023
Q4
$447K Buy
+4,241
New +$463K 0.02% 326
2023
Q1
Sell
-25,286
Closed -$2.06M 311
2022
Q4
$2.06M Buy
+25,286
New +$1.92M 0.29% 72

Other funds holding ORCL

Marex Group's ORCL Position: Q2 2026 in Review

Marex Group reduced its Oracle (ORCL) stake by 20% in Q2 2026, selling an estimated $27.8M and leaving 596,634 shares worth $87.4M. The position accounts for 0.37% of the portfolio, ranked #64.

Marex Group first reported a position in ORCL in Q4 2022 and has held it in 12 quarters since. The position peaked at $192M in Q4 2025. 3,518 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Marex Group held 596,634 shares of Oracle worth $87.4M as of Q2 2026.
  • Marex Group sold 153,253 Oracle shares in Q2 2026, an estimated $27.8M.
  • Oracle made up 0.37% of Marex Group's portfolio in Q2 2026, its #64 holding.
  • Marex Group first reported a position in Oracle in Q4 2022 and has held it in 12 quarters since.
  • Marex Group's Oracle position peaked at $192M in Q4 2025.
  • 3,518 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.